High dose-rate (HDR) brachytherapy (BT) provides a highly conformal method of dose delivery to the prostate. The purpose of this study is to prospectively determine the toxicity of the treatment protocol of 13.5 Gy × 2 fractions.
from Imaging via alkiviadis.1961 on Inoreader https://ift.tt/2IsK7Nb
Τρίτη 3 Απριλίου 2018
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: January 2017 Source: International Journal of Biological Macromolecules, Volume 94, Part A Author(s): Vinicius Jose Silv...
-
Background Moyamoya angiopathy (MMA) is characterised by a progressive stenosis of the terminal part of the internal carotid arteries and th...
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Shehwaz Anwar, Hina Youn...
-
Communicating with patients at the end of life is regarded as a difficult task, and speaking openly about death is often avoided.1,2 Around ...
-
Pyrexia is a physiological response through which the immune system responds to infectious processes. Hyperpyrexia is known to be neurodegen...
-
A. M. Y. Yong, SS Yang, KB Tan, SA Ho Indian Dermatology Online Journal 2017 8(3):192-194 The Trichosporon species are yeast-like opport...
-
Mucoepidermoid carcinoma is the most common malignant, locally invasive tumour of the salivary glands and accounts for approximately 35% of ...
-
Abstract The core mission of the Early Stage Professionals in Molecular Imaging Sciences (ESPMIS) Interest Group is to help young scientist...
-
BACKGROUND AND PURPOSE: Treatment with bevacizumab is standard of care for recurrent high-grade gliomas; however, monitoring response to ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου